Filing Details

Accession Number:
0001140361-10-016558
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-04-14 13:00:00
Reporting Period:
2010-04-12
Filing Date:
2010-04-14
Accepted Time:
2010-04-14 19:43:03
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1048477 Biomarin Pharmaceutical Inc BMRN Pharmaceutical Preparations (2834) 680397820
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1401782 Mark Wood 105 Digital Drive
C/O Biomarin Pharmaceutical Inc.
Novato CA 94949
Vp, Human Resources No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-04-12 937 $14.39 9,018 No 4 M Direct
Common Stock Disposition 2010-04-12 937 $23.81 8,081 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Acquisiton 2010-04-12 937 $0.00 937 $14.39
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
121,919 2009-11-21 2019-05-11 No 4 M Direct
Footnotes
  1. Transaction made pursuant to a Rule 105-1 Trading plan executed on September 2, 2009.
  2. The price in Column 4 is a weighted average price. The prices actually received range from $23.76 to $23.97. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
  3. Original option grant vests 6/48ths on November 21, 2009 and 1/48th on the 21st of each month thereafter.